Showing 1131-1140 of 1211 results for "".
- Incyte, Novartis to Evaluate JAK Inhibitor Ruxolitinib for Severe COVID-19 Patientshttps://modernod.com/news/incyte-novartis-to-evaluate-jak-inhibitor-ruxolitinib-for-severe-covid-19-patients/2477527/Incyte and Novartis announced that the companies plan to initiate a phase 3 collaborative study to assess ruxolitinib plus standard-of-care, versus standard care alone, in patients suffering from COVID-19-associated cytokine storm. The clinical trial will be sponsored by Incyte in the US, where t
- Novartis Asks Workers in Europe, US and Canada to Work From Homehttps://modernod.com/news/novartis-asks-workers-in-europe-us-and-canada-to-work-from-home/2477394/Due to the COVID-19 outbreak, Novartis released a statement requesting that effective today, its associates within the United States, Europe, and Canada to work from home, with the exception of those working in laboratories, manufacturing sites, and in the field. The measure is valid for 3
- ARVO Annual Meeting Cancelledhttps://modernod.com/news/arvo-annual-meeting-cancelled/2477380/Due to the COVID-19 outbreak, the Board of Trustees at The Association for Research in Vision and Ophthalmology (ARVO) has decided to cancel its annual meeting, scheduled to take place May 1–7 in Baltimore. The ARVO organizers released an emailed statement to its membership outlining the d
- Everads Therapy Enters Into Option Agreement to License Suprachoroidal Delivery System for Retinal Diseasehttps://modernod.com/news/everads-therapy-enters-into-option-agreement-to-license-suprachoroidal-delivery-system-for-retinal-disease/2477376/Everads Therapy announced that it has signed an option agreement with a large global pharmaceutical company, which will support the potential of its technology to overcome certain risks and side effects associated with current retinal disease treatment options, according to a company news release
- EMA Grants Two Product Designations to Janssen’s RPGR Gene Therapy for X-Linked Retinitis Pigmentosahttps://modernod.com/news/ema-grants-two-product-designations-to-janssens-rpgr-gene-therapy-for-x-linked-retinitis-pigmentosa/2477338/The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Medicines Agency (EMA) has granted both PRIME (PRIority MEdicines) and Advanced Therapy Medicinal Product (ATMP) designations to the company’s adeno-associated virus (AAV)-RPGR gene t
- Gemini Therapeutics and Singapore Eye Research Institute Enter Into Research Collaboration to Explore New Targets for AMDhttps://modernod.com/news/gemini-therapeutics-and-singapore-eye-research-institute-enter-into-research-collaboration-to-explore-new-targets-for-amd/2477327/Gemini Therapeutics announced a collaboration with the Singapore Eye Research Institute (SERI) to expand knowledge and identify new targets associated with AMD. Under the terms of the agreement, SERI and Gemini will explore the link between genetic and potential biomarkers in patients d
- Oxurion Presentation of Positive Topline Data from a Phase 1 Study Evaluating THR-687 for the Treatment of DMEhttps://modernod.com/news/oxurion-presentation-of-positive-topline-data-from-a-phase-1-study-evaluating-thr-687-for-the-treatment-of-dme/2477284/Oxurion NV announced that further positive topline data from a phase 1 study with THR-687, a novel, potent, pan-RGD integrin antagonist for the treatment of diabetic macular edema (DME), was presented by Arshad Khanani, MD, MA, Director of Clinical Research at Sierra Eye Associates, Reno, Nevada,
- EyeTech Launches EyeOn Ultra-Compact Eye-Tracking Tablet Platformhttps://modernod.com/news/eyetech-launches-eyeon-ultra-compact-eye-tracking-tablet-platform/2477269/EyeTech Digital Systems announced the launch of EyeOn, an all-in-one, ultra-slim eye gaze tablet during this year’s Assistive Technology Industry Association conference in Orlando. The EyeOn eye tracking platform enables people with mobility and motor impairments to select, type, and speak entire
- Think About Your Eyes Launches Enhanced Websitehttps://modernod.com/news/think-about-your-eyes-launches-enhanced-website/2477258/Think About Your Eyes, a national public awareness campaign by The Vision Council and the American Optometric Association, announced the launch of its new website. Featuring new content and a modern, easy-to-navigate design, the new platform provides information on eye health, eye conditions, vis
- Eyesight Philanthropist James Chen Awarded Honorary Degree by University of Bathhttps://modernod.com/news/eyesight-philanthropist-james-chen-awarded-honorary-degree-by-university-of-bath/2477169/James Chen, a philanthropist committed to solving global problems associated with vision and eye care, has been awarded an honorary degree from the University of Bath, UK. He received his honorary LLD (Doctor of Laws) degree at the Assembly Rooms, Bath, on Tuesday 10 December (12:15 pm). I